Wednesday, 8 September 2010

Cladribine tablets approved in Australia

From the MS Trust:
Australia has become the second country to approve cladribine tablets for the treatment of relapsing remitting MS. This follows its initial approval in Russia in July 2010, when it became the first oral MS treatment in the world to gain a licence.  For more click here